104 related articles for article (PubMed ID: 36194939)
21. Cervical Human Papillomavirus Infection (HPV) and High Oncogenic Risk Genotypes among Women Living with HIV in Asia: A Meta-Analysis.
Verrier F; Le Coeur S; Delory T
J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33924989
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.
Stier EA; Sebring MC; Mendez AE; Ba FS; Trimble DD; Chiao EY
Am J Obstet Gynecol; 2015 Sep; 213(3):278-309. PubMed ID: 25797230
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
[TBL] [Abstract][Full Text] [Related]
24. Relationship between Highly Active Antiretroviral Therapy (HAART) and human papillomavirus type 16 (HPV 16) infection among women in Sub-Saharan Africa and public health implications: A systematic review.
Menon S; Rossi R; Kariisa M; Acharya SD; Zdraveska N; Mahmood S; Callens S; Ndizeye Z
PLoS One; 2019; 14(3):e0213086. PubMed ID: 30856196
[TBL] [Abstract][Full Text] [Related]
25. Sexually transmitted infections among women living with HIV in a Brazilian city.
Tosato Boldrini NA; Bondi Volpini LP; Freitas LB; Spano LC; Musso C; Silva Santos MCLF; Barroso Dos Reis HL; Miranda AE
Braz J Infect Dis; 2021; 25(1):101044. PubMed ID: 33417851
[TBL] [Abstract][Full Text] [Related]
26. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
Heard I; Palefsky JM; Kazatchkine MD
Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
[TBL] [Abstract][Full Text] [Related]
27. Cervical Cytology and Herpes Simplex Virus Type-2 Serology Among Human Immune Deficiency Virus Infected Women on Highly Active Antiretroviral Therapy in Enugu, Nigeria.
Osinachi Ogu C; Uwadiegwu Achukwu P; Onubiwe Nkwo P; Ifeoma-Ossy Ogu R; Steven Onwukwe O; Chinonye Azubuike N; Obianuju Onyemelukwe A; Maryjoy Ifeorah I; Uzoamaka MC
Curr HIV Res; 2022; 20(6):463-471. PubMed ID: 36380408
[TBL] [Abstract][Full Text] [Related]
28. Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.
Kelly H; Faust H; Chikandiwa A; Ngou J; Weiss HA; Segondy M; Dillner J; Delany-Moretlwe S; Mayaud P
J Infect Dis; 2018 Aug; 218(6):927-936. PubMed ID: 29850832
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
30. Effect of highly active antiretroviral therapy (HAART) and menopause on risk of progression of cervical dysplasia in human immune-deficiency virus- (HIV-) infected women.
Kim SC; Messing S; Shah K; Luque AE
Infect Dis Obstet Gynecol; 2013; 2013():784718. PubMed ID: 24453469
[TBL] [Abstract][Full Text] [Related]
31. HPV oral lesions in HIV-infected patients: the impact of long-term HAART.
Anaya-Saavedra G; Flores-Moreno B; García-Carrancá A; Irigoyen-Camacho E; Guido-Jiménez M; Ramírez-Amador V
J Oral Pathol Med; 2013 Jul; 42(6):443-9. PubMed ID: 23278731
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
Fife KH; Wu JW; Squires KE; Watts DH; Andersen JW; Brown DR
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):274-82. PubMed ID: 19387354
[TBL] [Abstract][Full Text] [Related]
33. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
35. Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV.
Kaufman E; Williamson T; Mayrand MH; Burchell AN; Klein M; Charest L; Rodrigues-Coutlée S; Coutlée F; de Pokomandy A;
PLoS One; 2022; 17(5):e0268521. PubMed ID: 35587503
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis.
Ma X; Wang Q; Ong JJ; Fairley CK; Su S; Peng P; Jing J; Wang L; Soe NN; Cheng F; Zhang L
Sex Transm Infect; 2018 Sep; 94(6):434-442. PubMed ID: 29794242
[TBL] [Abstract][Full Text] [Related]
37. Cervical human papillomavirus prevalence, risk factors and outcomes in a cohort of HIV-infected women in Harare, Zimbabwe.
Mandiriri AM; Pascoe MJ; Shamu T; Lowe S
South Afr J HIV Med; 2020; 21(1):1123. PubMed ID: 33240535
[TBL] [Abstract][Full Text] [Related]
38. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
[TBL] [Abstract][Full Text] [Related]
39. Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
Bekolo CE; O'Bryan G; Tchago FE; Nangue C; Bekoule PS; Kollo B
PLoS One; 2016; 11(2):e0149152. PubMed ID: 26866371
[TBL] [Abstract][Full Text] [Related]
40. HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring.
McClung N; Mathoma A; Gargano JW; Nyepetsi NG; Querec TD; Onyekwuluje J; Mine M; Morroni C; Luckett R; Markowitz LE; Ramogola-Masire D
BMC Infect Dis; 2022 Feb; 22(1):176. PubMed ID: 35193517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
